Innovative drug concept stocks surged in the afternoon, ALK rose 2 limit-ups in 3 days, Frontier Biotechnologies hit the 20cm limit-up, and Staidson BioPharm and SDKX rose over 10%. On the news front, the National Healthcare Security Administration stated that it supports the use of healthcare insurance data for innovative drug research and development and reasonably determines the healthcare insurance payment standards for innovative drugs
Innovative drug concept stocks surged in the afternoon, ALK had two limit-ups in three days, Frontier Biotechnologies hit the 20% limit-up, and Staidson BioPharm and SDKX rose over 10%. On the news front, the National Healthcare Security Administration stated that it supports the use of healthcare insurance data for innovative drug research and development, and reasonably determines the payment standards for innovative drugs under healthcare insurance